2 results match your criteria: "NO.921 Hospital of the PLA Joint Logistic Support Force[Affiliation]"
Association between triglyceride glucose-body mass index and all-cause mortality in critically ill patients with acute pancreatitis.
Sci Rep
September 2024
Department of General Surgery, The Second Affiliated Hospital of Hunan Normal University, Changsha, 410008, Hunan, People's Republic of China.
This study delves into the correlation between the triglyceride glucose-body mass index (TyG-BMI) index upon hospital admission and clinical outcomes among this patient population. We investigated the association between TyG-BMI at hospital admission and clinical outcomes in this patient group, and analyzed data from the Medical Information Mart for Intensive Care IV database, identifying acute pancreatitis (AP) patients admitted to ICUs and stratifying them by TyG-BMI quartiles. We assessed the relationship between TyG-BMI and mortality (both in-hospital and ICU) using Cox proportional hazards regression and restricted cubic splines.
View Article and Find Full Text PDFEfficacy and safety of bimekizumab for the treatment of psoriasis: a systematic review and meta-analysis of randomized clinical trials.
J Dermatolog Treat
December 2023
Department of TCM Dermatology, NO.921 Hospital of the PLA Joint Logistic Support Force, Changsha, China.
Article Synopsis
- The study evaluated the effectiveness and safety of bimekizumab for treating psoriasis through a systematic review of randomized controlled trials (RCTs)!
- A total of six studies with 1252 participants showed that bimekizumab significantly improved psoriasis symptoms (like PASI scores) compared to a placebo group, with various levels of improvement reported!
- Results indicated that bimekizumab has a good safety profile, as there were no significant differences in adverse events between the bimekizumab and placebo groups!